The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 6
  • 1
    Kemlo, Philip James Gordon
    Company Director born in October 1990
    Individual (1 offspring)
    Officer
    2019-10-30 ~ now
    OF - Director → CIF 0
    Ms Philip James Gordon Kemlo
    Born in October 1990
    Individual (1 offspring)
    Person with significant control
    2019-10-30 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 2
    Cruz Gomes, Ariane Karla, Dr
    Company Director born in February 1991
    Individual (1 offspring)
    Officer
    2019-10-30 ~ now
    OF - Director → CIF 0
    Dr Ariane Karla Cruz Gomes
    Born in February 1991
    Individual (1 offspring)
    Person with significant control
    2019-10-30 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 3
    Kanji, Hussein
    Venture Capitalist born in October 1976
    Individual (25 offsprings)
    Officer
    2021-09-15 ~ now
    OF - Director → CIF 0
  • 4
    Macfarlane, James Oliver
    Venture Capital born in May 1988
    Individual (9 offsprings)
    Officer
    2021-03-17 ~ now
    OF - Director → CIF 0
  • 5
    Blight, Joshua Miles, Dr
    Company Director born in June 1991
    Individual (1 offspring)
    Officer
    2019-10-30 ~ now
    OF - Director → CIF 0
    Dr Joshua Miles Blight
    Born in June 1991
    Individual (1 offspring)
    Person with significant control
    2019-10-30 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 6
    NW BROWN DIRECTORS NOMINEES LTD - 2007-11-21
    GEIF NOMINEES LIMITED - 2006-04-18
    45, Whitfield Street, London, England
    Active Corporate (3 parents, 43 offsprings)
    Officer
    2024-01-05 ~ now
    OF - Director → CIF 0
Ceased 1
  • Palomaki, Parsi Pirkka
    Partner born in April 1970
    Individual
    Officer
    2021-03-17 ~ 2021-09-15
    OF - Director → CIF 0
parent relation
Company in focus

BASEIMMUNE LTD

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
112022-11-01 ~ 2023-10-31
82021-11-01 ~ 2022-10-31
Property, Plant & Equipment
61,434 GBP2023-10-31
79,598 GBP2022-10-31
Debtors
Current
610,489 GBP2023-10-31
343,987 GBP2022-10-31
Cash at bank and in hand
1,756,936 GBP2023-10-31
3,209,409 GBP2022-10-31
Current Assets
2,367,425 GBP2023-10-31
3,553,396 GBP2022-10-31
Creditors
Current, Amounts falling due within one year
-407,971 GBP2023-10-31
-208,574 GBP2022-10-31
Net Current Assets/Liabilities
1,959,454 GBP2023-10-31
3,344,822 GBP2022-10-31
Creditors
Non-current, Amounts falling due after one year
-290,667 GBP2022-10-31
Net Assets/Liabilities
2,020,888 GBP2023-10-31
3,133,753 GBP2022-10-31
Equity
Called up share capital
6 GBP2023-10-31
6 GBP2022-10-31
Share premium
4,150,971 GBP2023-10-31
4,150,971 GBP2022-10-31
Retained earnings (accumulated losses)
-2,130,089 GBP2023-10-31
-1,017,224 GBP2022-10-31
Equity
2,020,888 GBP2023-10-31
3,133,753 GBP2022-10-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
36,936 GBP2023-10-31
29,084 GBP2022-10-31
Office equipment
4,865 GBP2023-10-31
4,425 GBP2022-10-31
Computers
17,677 GBP2023-10-31
13,756 GBP2022-10-31
Property, Plant & Equipment - Gross Cost
102,728 GBP2023-10-31
90,515 GBP2022-10-31
Property, Plant & Equipment - Other Disposals
Plant and equipment
-1,850 GBP2022-11-01 ~ 2023-10-31
Property, Plant & Equipment - Other Disposals
-1,850 GBP2022-11-01 ~ 2023-10-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
3,014 GBP2022-10-31
Office equipment
430 GBP2022-10-31
Computers
3,815 GBP2022-10-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
10,917 GBP2022-10-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
9,568 GBP2022-11-01 ~ 2023-10-31
Office equipment, Owned/Freehold
1,531 GBP2022-11-01 ~ 2023-10-31
Computers, Owned/Freehold
5,041 GBP2022-11-01 ~ 2023-10-31
Owned/Freehold
30,557 GBP2022-11-01 ~ 2023-10-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Plant and equipment
-180 GBP2022-11-01 ~ 2023-10-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
-180 GBP2022-11-01 ~ 2023-10-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
12,402 GBP2023-10-31
Office equipment
1,961 GBP2023-10-31
Computers
8,856 GBP2023-10-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
41,294 GBP2023-10-31
Property, Plant & Equipment
Plant and equipment
24,534 GBP2023-10-31
26,070 GBP2022-10-31
Office equipment
2,904 GBP2023-10-31
3,995 GBP2022-10-31
Computers
8,821 GBP2023-10-31
9,941 GBP2022-10-31
Other Debtors
Current
599,542 GBP2023-10-31
339,799 GBP2022-10-31
Prepayments/Accrued Income
Current
10,947 GBP2023-10-31
4,188 GBP2022-10-31
Other Remaining Borrowings
Current
306,667 GBP2023-10-31
Trade Creditors/Trade Payables
Current
75,213 GBP2023-10-31
195,901 GBP2022-10-31
Other Creditors
Current
3,241 GBP2023-10-31
2,940 GBP2022-10-31
Accrued Liabilities/Deferred Income
Current
22,850 GBP2023-10-31
9,733 GBP2022-10-31
Creditors
Current
407,971 GBP2023-10-31
208,574 GBP2022-10-31
Other Creditors
Non-current
290,667 GBP2022-10-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
301,408 shares2023-10-31
300,000 shares2022-10-31
Par Value of Share
Class 1 ordinary share
0.000012022-11-01 ~ 2023-10-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
157,499 shares2023-10-31
157,499 shares2022-10-31
Par Value of Share
Class 2 ordinary share
0.000012022-11-01 ~ 2023-10-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
99,099 shares2023-10-31
99,099 shares2022-10-31
Par Value of Share
Class 3 ordinary share
0.000012022-11-01 ~ 2023-10-31
  • BASEIMMUNE LTD
    Info
    Registered number 12289125
    The London Bioscience Innovation Centre, Royal College Street, London NW1 0NH
    Private Limited Company incorporated on 2019-10-30 (5 years 8 months). The company status is Active.
    The last date of confirmation statement was made at 2024-10-29
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.